GlaxoSmithKline pulls Imus advertising prior to DJ’s dismissal

Share this article:
GlaxoSmithKline was among the advertisers to pull its ads from Don Imus’ talk show amid the controversy caused by remarks he made about the Rutgers University women’s basketball team. According to TNS Media Intelligence, GlaxoSmithKline was the No. 5 advertiser on the MSNBC telecast of Imus’ show during 2006, spending $277,900. “The bottom line is that we have suspended our advertising with MSNBC until we can determine that we can have a level of confidence that our media standards are being adhered to,” GlaxoSmithKline spokeswoman Nancy Pekarek told MM&M. Pekarek said Glaxo did not buy any advertising space on Imus’ radio program. “What we did do was buy advertising on MSNBC. That put us on a rotation and that’s how the ads appeared on MSNBC in that time slot,” she said. Glaxo was among a number of companies to remove their advertising from Imus’ show prior to the shock jock’s firing over racially insensitive remarks last week.
Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...